Webinar - Primary cells: An integral platform for immuno-oncology research

Overview


Scientists routinely use cell lines as healthy and diseased tissue models within drug development. They are easy to maintain, a stable platform and relatively inexpensive. However, they often do not reflect what is physiologically relevant in vivo. This is where primary cells may be a more advantageous choice for complex physiological disease and now an integral platform within Immuno-Oncology Research.


Venue: Web Event (Webinar)
Organiser Contact Details:
ELRIG

T: +447484113971
info@elrig.org

Delegates Registration



Webinar - Primary cells: An integral platform for immuno-oncology research
Blakey
Dr David Blakey
Chief Scientific Officer
MiNA Therapeutics
Speaker
Kremer
Kristina Kremer
Miltenyi
Speaker
Pattijn
Sofie Pattijn
ImmunXperts
Speaker

Eventflo Home
copyright ELRIG, eventflo, Labhoo Ltd 2003-2020